Page last updated: 2024-09-04

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and 1,2-dipalmitoylphosphatidylcholine

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with 1,2-dipalmitoylphosphatidylcholine in 8 studies

Compound Research Comparison

Studies
(dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination)
Trials
(dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination)
Recent Studies (post-2010)
(dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination)
Studies
(1,2-dipalmitoylphosphatidylcholine)
Trials
(1,2-dipalmitoylphosphatidylcholine)
Recent Studies (post-2010) (1,2-dipalmitoylphosphatidylcholine)
2198434,158201,262

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (62.50)18.2507
2000's3 (37.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashton, MR; Austin, NC; Hall, MA; Normand, IC; Postle, AD; Smith, DE1
Dechant, KL; Faulds, D1
Hall, SB; Holm, BA; Notter, RH; Venkitaraman, AR; Whitsett, JA1
Ishisaka, DY1
Belik, J; Duncan, JE; Hatch, GM1
Moen, MD; Perry, CM; Wellington, K1
Banerjee, R; Huilgol, N; Preetha, A1
Castro, R; Dixon, PS; Kerecman, J; Mustafa, SB; Vasquez, MM1

Reviews

3 review(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and 1,2-dipalmitoylphosphatidylcholine

ArticleYear
Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
    Drugs, 1991, Volume: 42, Issue:5

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Double-Blind Method; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1991
Exogenous surfactant use in neonates.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:4

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1996
Lucinactant: in neonatal respiratory distress syndrome.
    Treatments in respiratory medicine, 2005, Volume: 4, Issue:2

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Animals, Newborn; Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intercellular Signaling Peptides and Proteins; Peptides; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome; Surface Tension; Treatment Outcome

2005

Trials

3 trial(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and 1,2-dipalmitoylphosphatidylcholine

ArticleYear
Turnover of exogenous artificial surfactant.
    Archives of disease in childhood, 1992, Volume: 67, Issue:4 Spec No

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Birth Weight; Chromatography, High Pressure Liquid; Drug Combinations; Fatty Alcohols; Gestational Age; Humans; Infant, Newborn; Intubation, Intratracheal; Phosphatidylcholines; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1992
Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
    Drugs, 1991, Volume: 42, Issue:5

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Double-Blind Method; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1991
Exogenous surfactant use in neonates.
    The Annals of pharmacotherapy, 1996, Volume: 30, Issue:4

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn

1996

Other Studies

4 other study(ies) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and 1,2-dipalmitoylphosphatidylcholine

ArticleYear
Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
    The American review of respiratory disease, 1992, Volume: 145, Issue:1

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Adsorption; Albumins; Animals; Apoproteins; Biological Products; Cattle; Drug Combinations; Fatty Alcohols; In Vitro Techniques; Lung; Phosphorylcholine; Polyethylene Glycols; Proteolipids; Pulmonary Surfactants; Rats; Surface Tension; Surface-Active Agents

1992
Susceptibility of exogenous surfactant to phospholipase A2 degradation.
    Canadian journal of physiology and pharmacology, 1996, Volume: 74, Issue:8

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Acetylation; Animals; Biological Products; Cattle; Chemistry, Pharmaceutical; Drug Combinations; Fatty Alcohols; Hydrogen-Ion Concentration; Lysophosphatidylcholines; Phospholipases A; Phospholipases A2; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants

1996
Effect of fluidizing agents on paclitaxel penetration in cervical cancerous monolayer membranes.
    The Journal of membrane biology, 2007, Volume: 219, Issue:1-3

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Membrane Permeability; Drug Combinations; Fatty Alcohols; Female; Fluoresceins; Fluorescent Dyes; Humans; In Vitro Techniques; Liposomes; Membrane Fluidity; Membranes, Artificial; Models, Biological; Paclitaxel; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Surface-Active Agents; Uterine Cervical Neoplasms

2007
Immunosuppressive properties of surfactant in alveolar macrophage NR8383.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2008, Volume: 57, Issue:3

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Biological Products; Cell Line; Drug Combinations; Fatty Alcohols; Humans; Immunosuppressive Agents; Interleukin-1beta; Macrophages, Alveolar; Nitric Oxide; Nitric Oxide Synthase Type II; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactant-Associated Protein A; Pulmonary Surfactant-Associated Protein D; Pulmonary Surfactants; Rats; Respiratory Burst; Tumor Necrosis Factor-alpha

2008